OncLive SOSS

Authors

Insight From: Primo N. Lara, Jr, MD, UC Davis

Insight From: Robert L. Ferris, MD, PhD, Pittsburgh

Insights from: Wells A. Messersmith, MD, FACP, University of Colorado Cancer Center

Ira M. Klein, MD, MBA

Latest:

Oncology Enters the Informatics Era: Many Eager to Jump on the Health Information Highway

The unifying principle for care delivery in every situation should ideally be centered on complete clinical information, coupled with evidence-based medicine, and filtered through clinical decision support tools.

Ira Winer, MD, PhD

Latest:

Dr. Winer on the Tolerability of ALKS 4230 Plus Pembrolizumab in Ovarian Cancer

Ira Winer, MD, PhD, discusses the tolerability of ALKS 4230 plus pembrolizumab in ovarian cancer.

Latest:

Dr. Ghobrial on Antibodies for Multiple Myeloma Treatment

Irene Ghobrial, MD, director, Michele & Stephen Kirsch Laboratory, senior physician, Dana-Farber Cancer Center Institute, discusses the use of monoclonal antibodies for the treatment of multiple myeloma.

Irene Ghobrial, MD

Latest:

Disparities in Multiple Myeloma Care: The Path Toward Health Equity

Expert panelists share their closing thoughts on the path to improve health equity in multiple myeloma management for racial and ethnic minority groups.

Isaac Perlmutter Cancer Center

Isabel Preeshagul, DO, MBS

Isabel Preeshagul, DO, MBS, a thoracic medical oncologist and assistant attending physician at Memorial Sloan Kettering Cancer Center in Montvale, New Jersey.

Latest:

Cost-Effectiveness and Closing Perspectives in Early-Stage NSCLC

Panelists discuss how financial toxicity and cost-effectiveness analyses highlight the importance of appropriate patient selection for perioperative immunotherapy, while emphasizing that multidisciplinary care and patient involvement remain essential for optimal outcomes.

Isabella C. Glitza, MD

Latest:

Dr. Glitza on Intrathecal Nivolumab Approaches in Leptomeningeal Disease

Isabella C. Glitza, MD, discusses a single-center phase I/Ib trial of concurrent intravenous and intrathecal nivolumab for patients with metastatic melanoma and leptomeningeal disease.

Ismail Baris Turkbey, MD

Latest:

Dr. Turkbey on Sodium Fluoride PET Imaging for Prostate Cancer

Ismail Baris Turkbey, MD, staff clinician in the Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, discusses sodium fluoride PET imaging for patients with prostate cancer.

Istvan Pataki, MD

Latest:

Voice Recognition Systems Save Time and Money

Due to a variety of factors, today’s oncologists face multiple challenges in collecting, managing, and sharing their patients’ health data.

Ivan M. Borrello, MD

Latest:

Dr. Borello on Treating Indolent Versus Aggressive Relapsed Multiple Myeloma

Ivan M. Borrello, MD, discusses treatment for patients with indolent versus aggressive relapsed multiple myeloma.

Ivan M. Borrello, MD, Johns Hopkins Kimmel Cancer Center

Ivan Marques Borello, MD, Johns Hopkins

Ivan Marques Borello, MD, Johns Hopkinsk

Ivan Marques Borrello, MD, Johns Hopkins University

Ivy Altomare, MD, Duke

Ivy Altomare, MD, Duke&nbsp